Skip to content
10-Q

Quarterly Report

NxStage Medical, Inc.

0001333170-17-000011

← back to feed
Filed
May 9, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Apr 30, 2017 65.74M sh
Long Term Debt Q1 2017 · Mar 31, 2017 $1.24M
Long Term Debt Q1 2017 · Dec 31, 2016 $1.31M
Short Term Debt Q1 2017 · Mar 31, 2017 $334K
Short Term Debt Q1 2017 · Dec 31, 2016 $328K
Stockholders Equity Q1 2017 · Mar 31, 2017 $210.51M
Stockholders Equity Q1 2017 · Dec 31, 2016 $201.4M
Current Liabilities Q1 2017 · Mar 31, 2017 $47.7M
Current Liabilities Q1 2017 · Dec 31, 2016 $49.26M
Total Liabilities Q1 2017 · Mar 31, 2017 $112.95M
Total Liabilities Q1 2017 · Dec 31, 2016 $115.13M
Current Assets Q1 2017 · Mar 31, 2017 $151.23M
Current Assets Q1 2017 · Dec 31, 2016 $144.9M
Total Assets Q1 2017 · Mar 31, 2017 $323.78M
Total Assets Q1 2017 · Dec 31, 2016 $317.21M
Capex Q1 2017 · Mar 31, 2016 $3.36M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $57.71M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $59.07M
Sga Expense Q1 2017 · Mar 31, 2016 $8.03M
Rd Expense Q1 2017 · Mar 31, 2016 $7.15M
Net Income Q1 2017 · Mar 31, 2016 −$1.28M
Operating Income Q1 2017 · Mar 31, 2016 −$975K
Gross Profit Q1 2017 · Mar 31, 2016 $36.52M
Cost Of Revenue Q1 2017 · Mar 31, 2016 $52.69M